ThetaOwl

MRNA Earnings Report

Analysis based on market close March 31, 2026

Earnings Verdict

Earnings expected ~Apr 30 (31 days out). IV is extremely elevated (81%), making IV crush plays attractive. The stock is pinned near max pain with strong gamma support, suggesting a contained move. Historical EPS beats support a potential upside surprise, but the high-vol market regime adds risk.

Confidence:
6.5 / 10
base 5; +1 high IV (81%) for crush; +0.5 consistent EPS beat history; -0.5 elevated VIX regime; -0.5 gamma pinning near spot
Most important: IV term structure shows a sharp kink at May 1 (31d) expiration to 72.4%, confirming the implied earnings date and offering a clear crush target.
⚠️Earnings date is implied from IV kink at May 1 expiration (~Apr 30). Confirm via company IR.
📈100% EPS beat rate last 4 quarters provides a directional bias for potential upside surprise.
🎯Stock pinned near max pain ($52) with high GEX. Expect resistance to large moves until earnings.

Regime Classification

Vol Regime
High (IV 81%)
Gamma Regime
Pinning (GEX +$28.9M — mean-reverting)
Flow Regime
Mixed (net prem $-49.4M, P/C 0.85)
Spot vs MP
Below max pain by 2.3% (spot $50.80 vs MP $52)
Gamma flip: ~$25.00Estimated ~$25 based on put OI concentration. Below this, dealer hedging could amplify downside moves.

Earnings Overview

Next earnings: 2026-04-30 (31 days)implied (IV kink at May 1 expiration)

Expected moves:

  • 5/01 (31d): ±$8.53 (16.8%) [$42.27 - $59.32]

IV Setup

Term structure: Sharp kink at May 1 (31d) to 72.4% vs 67.7% (Apr 24) and 75.0% (May 8). Front-week (Apr 2) IV at 71.2% is also elevated.

Crush estimate: ~10-15 vol pts post-earnings, back to ~60-65% range.

Skew: P/C OI ratio near 1.00 indicates balanced positioning. Unusual deep OTM put flow (e.g., $85, $135 Dec'26) suggests long-term hedging/tail risk buying.

Historical Context

Beat rate: 100% (4/4 quarters)

Avg move vs expected: No price move data provided, but consistent EPS beats suggest positive directional bias.

Directional bias: Implied positive given 100% EPS beat rate over last 4 quarters.

Key Levels

1$52 max pain (near-term)
2$50 call OI wall (25,550)
3$40 put OI wall (14,290)
4EM: $42 - $59

Flow Highlights

Massive net put premium at strikes $200, $230, $135, $125 (millions $ negative net).

Institutional long-dated downside hedging or tail-risk purchases, not directly related to near-term earnings.

Large $30 call net premium (+$1.42M).

Significant bullish flow at a deep ITM strike, possibly for financing or delta exposure.

Strategies

Short Iron Condor (IV Crush)
Sell $42.5/$40P x $59/$61C 5/01
Credit: $1.50-$2.00
Max loss: $3.50
Max gain: $1.75
BE: $41.75 / $59.25
Trigger: Enter 5-7 days before expected earnings (late April).
Capitalizes on extreme IV (81%) and expected crush. Strikes calibrated just outside the expected move to provide a cushion, acknowledging historical beats.
Outperforms: Stock stays within the 16.8% expected move bounds and IV crushes post-earnings.
Underperforms: Stock gaps beyond short strikes ($40 or $61).
Long Put Calendar Spread (Directional Bearish/Vol Play)
Buy $50 put 5/01 (long), Sell $50 put 4/24 (short)
Max loss: Debit paid
Max gain: Theoretical: short put decays rapidly post-earnings while long put retains longer-dated vol.
BE: Complex; benefits from IV crush on short leg and spot below $50.
Trigger: Enter 1-2 weeks before earnings.
Targets the gamma pinning at $50/$52 and high front-week IV. Benefits from crush on the short-dated option while maintaining longer-dated optionality. Aligns with spot below near-term max pain.
Outperforms: Stock is at or below $50 post-earnings and IV crushes sharply on the front week (Apr 24).
Underperforms: Stock rallies sharply or IV does not crush as expected.
Long Straddle (Directional Breakout)
Buy $51 straddle 5/01
Max loss: Debit paid (~$8.53 estimated cost based on EM)
Max gain: Unlimited
BE: $42.47 / $59.53 (using EM as cost proxy)
Trigger: Enter if IV dips into earnings or on a volatility pullback.
High historical beat rate and elevated IV can lead to larger-than-expected moves. The straddle buys the expected move, betting on an overshoot. Risk is high due to expensive premium.
Outperforms: Actual move exceeds the 16.8% expected move by a significant margin (>30%).
Underperforms: Stock pins near $51 and IV crushes post-earnings.

Risk Assessment

!Gap Risk: Expected move is wide (±16.8%). A binary outcome on pipeline/news could cause a gap beyond strikes.
!IV Crush Impact: Critical for short premium strategies. If VIX remains elevated, crush may be less severe.
!Liquidity: Options are liquid (768k OI) but not hyper-liquid. Focus on strikes with high OI ($40, $50, $53, $56).
!Sizing: Size small due to high volatility and binary event nature. High IV means wide bid-ask spreads.

What to Watch

?IV trajectory into late April — any spike above 85% favors short premium.
?Spot price action relative to $52 max pain and $50 gamma level.
?Unusual activity in May 1 expiration for confirmation of positioning.

Read the Earnings analysis for MRNA for 2026-03-31. This AI-generated report covers regime classification, key price levels, strategy recommendations, and actionable trade ideas drawn from end-of-day options data including gamma exposure, delta exposure, and implied volatility.